Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Seven more marketing approvals announced for Campto

Aug. 4, 1997

Apoptosis Technology and BioChem Pharma to collaborate on anticancer agents

Aug. 4, 1997

Janssen reports farnesyl protein transferase inhibitors

Aug. 4, 1997

Nutraceutix in-licenses breast cancer preventive agent

Aug. 4, 1997

Lexicon Genetics granted NIH grant for DNA repair research

Aug. 4, 1997

AEterna reports promising safety profile for Neovastat

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Daiichi's new anticancer agent enters overseas clinical trials

July 30, 1997

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...